• News
  • Money

Takeda Agrees To Buy Shire In £46bn Deal

Takeda Agrees To Buy Shire In £46bn Deal

Takeda yesterday announced that the boards of the two companies "have reached agreement on the terms of a recommended offer pursuant to which" the Japanese firm would buy Shire. The deal is expected to close sometime in the first quarter of 2019, pending review by regulators in a number of countries including the U.S., EU, Japan and China.

The deal, which values Shire at £46bn ($62bn), will see Takeda become one of the 10 largest pharmaceutical companies in the world by sales, as well as putting the company in a leading position in the treatment of rare diseases.

The formal offer comprises $30.33 in cash and either 0.839 new Takeda shares or 1.678 new Takeda American depository shares (ADSs) per Shire share. "Takeda is offering Shire shareholders a mixture of cash and stock".

The price tag has alarmed investors in Takeda: Its shares are down 18% since it first revealed it was considering an approach for Shire in late March.

An afternoon recap of the day's most important business news, delivered weekdays.

Creating a global giant based in Japan with an attractive geographic footprint.

The enlarged company would also probably face a higher tax bill, although Takeda's has not run the numbers.

"We can now go after targets and diseases that we couldn't previously", said Plump, who oversees Takeda's research and development operations, which are based in MA.

Overall, it appears Takeda made five public bids for Shire. By mid-morning London time, it was trading at £40.04, reflecting continued uncertainties about the feasibility of the deal and the large component of Takeda paper contained therein. Shire books a majority of its sales in the USA, where the long term industry outlook is brighter and pricing is more permissive.

Shire, founded in Basingstoke, Hampshire, in 1986, makes ADHD drugs Adderall and Vyvanse and the dry-eye drops Xiidra, as well as treatments for rare diseases.

Under CEO Weber, Takeda has looked outside of its home market for opportunities to expand in its core areas of gastroenterology, cancer and neuroscience. Their drug pipelines are running dry, and their portfolios of patent-protected medicines shrinking.

Japanese firms in particular are facing pressure domestically as the government tries to cut prices of many branded drugs and increase the focus on cheaper generics to curb health spending as the population ages rapidly. Now it must do likewise with Shire's investors - as well as its own. The companies indicated in late April they had reached a preliminary deal valued at £46 billion, or US$64 billion, based on a stronger exchange rate for the pound at the time.

During this period, Shire sold its oncology business to France's Servier for $2.4 billion.

Leave Your Comment

Leave Your Comment


Latest News

Breaking News



Recommended

Tenacious D Announces Sequel To "The Pick Of Destiny"

The original Pick Of Destiny movie did $8.2 million in the box office and received pretty mixed reviews across the board. The film's multitude of cameo players included Dave Grohl , Tim Robbins, Amy Adams, Ben Stiller and Meat Loaf.

Calvin Harris involved in auto crash

Shortly after police attended the crash scene, where the DJ and his girlfriend exchanged insurance details with the other parties. TMZ also writes that the two girls driving the Honda claimed that " Calvin nor Aarika asked if they were okay".

Did Dish Network call you? If so, you may get $1200

That's because of a telemarketing lawsuit brought against the satellite TV provider. "'Yeah, right' is my first thought". Lawyers say they are encountering similar scenarios when they call clients to tell them they may be awarded money.

Israel offends Japanese PM by serving him dessert in a shoe

A Japanese diplomat was similarly appalled, saying there was no culture on Earth that would put shoes on a table. According to the Post report, the initial statement of the ministry said: "We respect and appreciate the chef.

Walmart, not Amazon, will acquire Indian market leader Flipkart

The Flipkart buy may be one of the largest deals in the retail sector and the biggest in the e-commerce market. Walmart is putting resources into fighting a tough battle against its online competitors, not least Amazon .

California set to require solar on most new homes

On the contrary, environmentalists approve of the new standards. "That net-zero home is not a net-carbon-zero home". Herro, the vice president of environmental affairs for Meritage Homes , told the Orange County Register .

Good News For Music Lovers Of Instagram

It would give the feature a leg up on Snapchat Stories which is where Instagram got this feature from in the first place. If users could make sing-along videos on Instagram, they likely wouldn't need to use Musical.ly for the same goal .

Trump Urges West Virginia Republicans to Oppose Blankenship

Blankenship rejects the comparisons to Moore, which were amplified when the president urged voters Monday to "Remember Alabama". McConnell is married to Transportation Secretary Elaine Chao, who is from Taiwan and whose family owns a shipping company.

NPAs hit net; ICICI Bank rolls out new strategy

The bank is targeting to bring down net NPA to 1.5 per cent and take the provision coverage ratio to 70 per cent by March 2020. The board of directors of ICICI Bank did not discuss the controversy arising from ICICI Bank's loan to the Videocon group.

Microsoft shows off Cortana and Amazon Alexa integration at Build 2018

At the time, users were demoed using handoff triggers to utilize both Alexa and Cortana in a weird 3-way conversation example. But there were some concerns those commands would be awkward, and that integrations like this could be unnecessary too.